HighGravityDataFMC Corporation — Jul 29, 2026 release
Fiscal 2026 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000037785-26-000139
Showing in the filing
Debt-reduction proceeds target
“approximately $1 billion of proceeds”
Period
FY2026
Measure
Company-defined measure
Source
Prose
All guidance in this release · 35
Revenue excluding India (full-year) for FY2026
“a range of $3.50 billion to $3.70 billion”
Adjusted EBITDA (full-year) for FY2026
“a range of $620 million to $680 million”
Adjusted earnings per diluted share (full-ye… for FY2026
“a range of $1.19 to $1.49”
Free cash flow (full-year) for FY2026
“increased to a range of $75 million to $225 million”
Debt-reduction proceeds target for FY2026
“approximately $1 billion of proceeds”
Proceeds to be used for debt paydown
“approximately $1 billion”
Price (full-year outlook) for FY2026
“expected to be lower by mid-to-high single digits”
Volume excluding India (full-year outlook) for FY2026
“expected to be in line with prior year”
India headwind (full-year outlook) for FY2026
“a 2 percent headwind”
Revenue excluding India for Q3 FY2026
“expected to be in the range of $840 million to $900 million”
Revenue Excl. India for Q3 FY2026
“$840 million to $900 million”
Volume for Q3 FY2026
“expected to be lower”
Adjusted EBITDA for Q3 FY2026
“forecasted to be in the range of $120 million to $140 million”
Adjusted EBITDA for Q3 FY2026
“$120 million to $140 million”
Adjusted earnings per diluted share for Q3 FY2026
“in the range of $0.05 to $0.13”
Adjusted earnings per diluted share for Q3 FY2026
“$0.05 to $0.13”
Revenue excluding India for Q4 FY2026
“expected to be in the range of $1.06 billion to $1.20 billion”
Revenue Excl. India for Q4 FY2026
“$1.06 billion to $1.20 billion”
Volume for Q4 FY2026
“expected to show healthy growth”
Adjusted EBITDA for Q4 FY2026
“forecasted to be in the range of $275 million to $315 million”
Adjusted EBITDA for Q4 FY2026
“$275 million to $315 million”
Adjusted earnings per diluted share for Q4 FY2026
“in the range of $1.09 to $1.33”
Adjusted earnings per diluted share for Q4 FY2026
“$1.09 to $1.33”
Adjusted EPS for Q4 FY2026
“$1.09 to $1.33”
Revenue for FY2026
“$3.50 billion to $3.70 billion”
Revenue Excl. India for FY2026
“$3.50 billion to $3.70 billion”
Growth at midpoint vs. 2025 (Revenue Excl. I… for FY2026
“(7)%”
Growth at midpoint vs. 2025 (Revenue Excl. I… for Q3 FY2026
“(9)%”
Growth at midpoint vs. 2025 (Revenue Excl. I… for Q4 FY2026
“4%”
Growth at midpoint vs. 2025 for Q4 FY2026
“4%”
Adjusted EBITDA for FY2026
“$395 million to $455 million”
Growth at midpoint vs. 2025 for Q3 FY2026
“(45)%”
Adjusted EPS for FY2026
“$1.19 to $1.49”
Adjusted EPS for Q3 FY2026
“$0.05 to $0.13”
Diluted shares assumed for EPS estimates for Q3 FY2026
“125.9 million diluted shares”
Exhibit 99.1 · the passage around this item
… earlier in the release
These pillars remain the foundation of the company's plan to improve earnings and cash generation, positioning FMC to take full advantage of its technology-driven growth potential. During the quarter, FMC announced the key components of its targeted approximately $1 billion of proceeds to be used for debt reduction. These actions included signing a definitive agreement for the sale of its India commercial business for $252 million, closing on a licensing agreement for rimisoxafen with Corteva for an upfront payment of $200 million, signing a sale-leaseback agreement for its Newark, Delaware property for $114 million and reaching an agreement for a $400 million equity investment from Tessenderlo Group. With these actions and other minor asset sales to be completed this year, FMC expects to generate approximately $1 billion of proceeds to be used for debt paydown. The India 3 Page 4 / FMC Corporation reports second quarter 2026 results including with Adjusted EBITDA above high end of guidance range and solid cash generation commercial business sale, the Newark, Delaware property sale and the Tessenderlo Group investment are subject to various closing conditions, including regulatory approvals. With these actions in place, the FMC Board of Directors has concluded the exploration of strategic options announced in February 2026. The company remains focused on executing its operational priorities and strengthening the foundation for future growth through its different
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.